Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

158
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
158
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

207
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
207
Menopause01:28

Menopause

3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

189
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
189
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

162
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
162

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late-onset hypogonadism and lower limb vascular complications in men with type 2 diabetes: an observational study in a tertiary care centre.

Journal of endocrinological investigation·2026
Same author

HbA1c variability as an independent risk factor for diabetic retinopathy: results from a screening program.

Acta diabetologica·2026
Same author

Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database.

Pharmacological reports : PR·2026
Same author

Angiogenic T cells and cognitive function in older adults with type 2 diabetes treated with GLP-1 receptor agonists.

Aging clinical and experimental research·2026
Same author

Ethanol ablation of cystic thyroid nodules: institutional experience with one year follow-up.

La Radiologia medica·2026
Same author

Ablation of cystic thyroid nodules with or without the injection of ethanol prior to aspiration: a one-year follow-up study.

Updates in surgery·2026
Same journal

Associations of metabolic heterogeneity of obesity with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): longitudinal cohort and cross-sectional study.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

Ubiquitination-anchored signature defines neuroendocrine prostate cancer: hub genes and single-cell ecosystem insights from integrated bioinformatics analysis of public transcriptomic datasets.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

SPISE index and ensemble machine learning refine cardiovascular risk stratification in stage 0-3 CKM syndrome.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

Relationship between Chinese visceral adiposity index and bone mineral density in patients with type 2 diabetes mellitus.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

Testosterone deficiency in aging males: a dual threat to vascular and bone health through coronary artery calcification and osteoporosis - a narrative review.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

The effect of dutasteride on storage symptoms in men with lower urinary tract symptoms: a REDUCE trial analysis.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
See all related articles

Related Experiment Video

Updated: Jan 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

734

Aging and erectile function.

David R Meldrum1,2, Marge A Morris3, Joseph C Gambone4

  • 1Department of Reproductive Medicine, University of California San Diego, San Diego, CA, USA.

The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|November 15, 2019
PubMed
Summary
This summary is machine-generated.

Optimizing erectile function involves addressing vascular nitric oxide, nutrition, exercise, and weight control. Combining these lifestyle and medical interventions maximizes benefits for erectile, vascular, and overall health.

Keywords:
Erectile dysfunctioninsulin resistancenitric oxideobesityoxidative stresspelvic floor exercises

More Related Videos

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

15.0K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.9K

Related Experiment Videos

Last Updated: Jan 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

734
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

15.0K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.9K

Area of Science:

  • Urology
  • Cardiovascular Health
  • Metabolic Health

Background:

  • Erectile dysfunction (ED) is influenced by a complex interplay of physiological and biochemical factors.
  • Vascular health, nutrition, and metabolic status are critical determinants of erectile function.
  • Numerous lifestyle and medical factors contribute to the development and management of ED.

Purpose of the Study:

  • To review and discuss the multifaceted factors influencing erectile function.
  • To highlight the interactions between various determinants of erectile health.
  • To provide a comprehensive overview of evidence-based interventions for improving erectile function.

Main Methods:

  • Literature review and synthesis of published research on erectile function.
  • Analysis of factors including vascular nitric oxide, nutrition, exercise, and weight management.
  • Examination of the role of hypertension, oxidative stress, inflammation, and pelvic floor strength.

Main Results:

  • Vascular nitric oxide, nutrition, exercise, and weight control are crucial for erectile function.
  • Maintaining insulin sensitivity and early hypertension management are important.
  • Reducing oxidative stress (e.g., from obesity, smoking) and inflammation (e.g., gingivitis) are beneficial.
  • Improving pelvic floor muscle strength and inhibiting cyclic GMP breakdown are key targets.

Conclusions:

  • Interventions targeting erectile function impact diverse biochemical and physiological pathways.
  • A multifactorial approach combining various therapeutic strategies is essential.
  • Integrated interventions offer maximal benefits for erectile, vascular, and general health.